DBT, Cipla get Thomson Reuters India innovation awards

Our Bureau, New DelhiSaturday, November 24, 2012, 08:00 Hrs  [IST]

Four organisations, including the Department of Biotechnology (DBT) and pharma major Cipla, have been recognised as India’s most innovative and named as the recipients of the Thomson Reuters India Innovation Awards 2012.

First established in 2007, the Awards recognise the most innovative academic institutions and commercial enterprises headquartered in India for their spirit of innovation in Research & Development (R&D).

In a ceremony held here on Thursday, the awards were presented by Harkesh Kumar Mittal, advisor, Member Secretary of the National Science & Technology Entrepreneurship Development Board (NSTEDB) and secretary of the Technology Development Board (TDB), across four different industrial sectors. In the category of pharma academic and government, the DBT was awarded while the Cipla Ltd won the recognition in the category of pharma corporate.

“Innovation drives economic growth and success. Thomson Reuters is pleased to recognise India’s collective achievements in innovation as Indian companies and research organisations expand their global footprint and research influence rapidly in an increasingly complex and competitive environment,” said Vinay Singh, director, India, Intellectual Property & Science business of Thomson Reuters.

The four award recipients were selected based on research and analysis using Thomson Reuters Derwent World Patents Index, Derwent Patent Citations Index and Thomson Innovation. The 2012 Award recipients are decided by analysing their innovation through patented technology as recorded in Thomson Reuters patent information services.